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SUMMARY
The intracellular As-protein binding in cytosol and methanol–water extract of the auricle and saphene tissues of As impacted people was evaluated by bidi-
mensional size exclusion FPLC-UV-ICP-MS. The fractionation of cytosol using Superdex, Phenomenex and MonoQ HR 5/5 columns, shows that As was distrib-
uted in a wide range of contiguous fractions of each column, being 8, 25, 50 % the percentages of As in the collected fractions, respectively. 
Arsenic a sulphur coelute when FPLC–UV–ICP–MS was applied, which could implicate that As is bound to bio-compounds of different molecular mass 
through vicinal sulphur groups. The monitoring of S, Cu and P. In the methanol: water extracts a similar study than performed with the cytosol using preparative 
gel chromatography on Sephadex G-75 and Shephadex G-100 columns. A very low As and protein contain were found in the different fractions of both SEC 
fractionating series. A similar As–protein association to that found in the cytosol after fractionating with MonoQ HR 5/5 was observed for auricle and saphene.
Inorganic and methylated As speciation in the 20 - 26 cytosol fractions obtained within the Phenomenex column was performed by HPLC–ICP–MS using the 
Hamilton PRP-X100 column. Only As(III) and As(V) were present and the results obtained shows that the As(III)/As(V) ratio is constant in most cases.
Direct evidence of the existence of As–binding peptides in auricle and saphene vein from arsenic impacted human beings has have been obtained which was 
previously reported by means of  novo peptide synthesis.
INTRODUCTION
The danger of As for human health is associated with cancer and non-
cancer effects, apart from that its genotoxicity is broadly reported1. However 
also a certain essential character had to be assigned to As, in this case, experi-
ments with mammalian model species2, not associated to enzymes. The toxicity 
and the mitigation damaging effect may be related with promote of the folding 
or degradation of altered proteins or with limiting the synthesis of new proteins 
that may be altered by arsenite. Another aspect to take into account is detoxifi-
cation mechanisms of As in the organisms3.
The reactivity of As(III), as a soft metal ion which forms strong bonds with 
functional groups such as thiolates of cysteine and the imidazolium nitrogens 
of histidine residues, permits to deduce that the understanding of interaction 
of As ions with proteins is essential in order to understand the mechanisms 
governing the bioinorganic chemistry related with the biological activity of 
arsenic.  As(III) is toxic because it is able to form organo-metal bondings with 
metal-thiol sidegroups in vicinal cysteines of enzymes such as pyruvate dehy-
drogenase at their activity centres4. As(V) disrupts oxidative phosphorilation by 
substituting phosphate in the formation of ATP. As binding to various cytosolic 
proteins and methylation through the methylating agent S–adenosylmethionine 
(SAM) governed by the ATP as well as arsenite and arsenate methyltransferase 
are considered competitive mechanisms for As detoxification5. However, com-
pelling experimental evidence obtained by several laboratories is suggesting 
that biomethylation, particularly the production of methylated metabolites that 
contain As(III), is a process that activates As as a toxin and a carcinogen6. Thus 
there is evidence that the attachment of inorganic As to proteins and subsequent 
arsenic extrusion mechanisms by means of cytosol As binding proteins may be 
the prevalent detoxification mechanism.
The most important findings referring to As binding on proteins may be 
summarized as follows: i) Arsenic binds a variety of cytosolic proteins and 
macromolecular constituents of tissues from both, methylating and non meth-
ylating (Mamoset monkey) animals7; ii) As is bound to hemoglobin through 
vicinal –SH groups in spleen, bone marrow (high hemoglobin content) and in 
plasma and packed cells. iii) As is bound to 100 kDa, 450 kDa and > 2000 kDa 
size proteins in liver cytosol in the livers of mammalian animals8.
 Relatively 
few studies about As binding to proteins in humans have been carried out9. The 
inorganic As content in serum from peritoneal dialysis patients was attached to 
both, high molecular mass protein (about 80 000 Da) and low molecular mass 
species (< 1000 Da), whereas arsenobetaine (AsB), although present in the 
former fraction, was not attached to the proteins8.
There are four arsenic binding proteins of 50, 42, 38.5, and 19.5 kDa. Two 
of them were tentatively identified as turbulin (50 kDa) and actin (42 kDa), 
which are induced by As(III) in human lymphoblastoid cells8. As(III) bind-
ing to proteins is most likely to be an As(III) association to three thiol groups 
arranged in a specific spatial relationship, as proposed by Rosen4. Recently, it 
has been shown by de novo peptide synthesis that As(III)–cysteine interactions 
stabilise three–helix bundles in aqueous solutions4. 
The high concentration of As associated with copper mining activity and 
water supply in the Chilean II Region (about 800 µg L-1 in the period 1950-
1970, decreasing in the actuality to values around 50 µg L-1) is probably related 
with occurrence of cancer in this region, as well as with non-cancer symp-
tomns such as abnormal pigmentation, acrocyanosis, hyperkeratosis, gangrene 
of fingers, ischemia of the tongue, diabetes, Raynand´s syndrome, thrombosis, 
cerebral vascular disease, coronary artery occlusions and other cardiovascular 
diseases (CVD)10,11. 
In a precedent study the distribution of As and As species in three heart 
tissues (auricle, mammary artery and fat) and in saphene vein (used as by-pass) 
was investigated. Samples were taken from individuals chronically exposed to 
arsenic in the Chilean II Region, suffering cardiovascular diseases (CVD) and 
subjected to hearth surgery in Antofagasta, Chile.  It could be demonstrated 
that the main species in the auricle and saphene tissues was As(III), followed 
by As (V). DMA could only be detected in the saphene tissue12.
In this work we have evaluated the intracellular As-protein binding by 
size exclusion (SE)-Fast Protein Liquid Chromatography (FPLC) with visible 
range (UV) and Inductively Coupled Plasma Mass Spectrometer (ICP-MS) de-
tection in auricle and saphene tissues of the same group of persons in order to 
understand the effect of long term exposure to high concentrations of As on the 
cardiovascular system. Besides S, P and Cu were monitored together with As. 
The As species present in SE relevant fractions have further been deter-
mined by Anion Exchange   Liquid Chromatography (AELC-ICP-MS).
EXPERIMENTAL
Samples
The auricle tissue and saphene vein of six persons operated in the Antofa-
gasta Hospital of coronary thrombosis and presenting high As content in both 
tissues were taken for this study. The samples were obtained from a population 
under study, made up of patients who have lived at least five years in the II 
Region of Chile13. Specific patient characteristics can be found in precedent 
work10 and also in Table 1.
Instrumentation.
Before size exclusion and gel fractionating medium pressure liquid chro-
matography experiments (SE–GF–MPLC), the homogenisation and centrifu-
gation of the tissues were made at 4 º C in a agate mortar and a Eppendorf 
centrifuge 5804 R (Germany). These gel chromatography procedures for 
protein fractionating were made employing tap water thermostated jacket and 
inert Merck Superformance Universal Glass Cartridge System (50 x 26 mm 
id) (Germany) packed with Sephadex G–75 and G–100 gels, coupled to a Shi-
e-mail: ipizarro@vantof.cl
J. Chil. Chem. Soc., 58, Nº 4 (2013)
2072
madzu LC– 10AS (Japan) chromatography pump via a Pharmacia Fine Chemi-
cals SRV–3 valve and a SA–50 sample applicator (Uppsala, Sweden), and to a 
Gilson FC 203 fraction collector (France).
A Hydride Generation Atomic Fluorescence Spectrometer (HG-AFS) (Ex-
calibur, PSA, UK) to determine the total As content was used. 
An Inductively Coupled Plasma Mass Spectrometer (ICP–MS) HP 4500 
(Yokogawa Analytical Systems, Tokyo, Japan) was used fitted with a Babing-
ton glass nebulizer and a Scott double pass spray chamber cooled by a Pel-
tier system, which was employed as an “off line” detector after gel filtration 
chromatography (GFC) fractionation, and as an “on-line” detector for arsenic 
speciation by  anion exchange liquid chromatography (AELC-ICP-MS) and for 
arsenic binding protein fractionation by anion protein exchange,namely Fast 
Protein Liquid Chromatography (FPLC-UV-ICP-MS).  Single ion monitoring 
at m/z 75 was used to collect the data. 
Anion exchange liquid chromatography (AELC) for  inorganic and meth-
ylated As speciation was performed with an High-performance liquid chro-
matography (HPLC) system Division Riviera Beach, Florida, USA). 100 µL 
of sample were introduced into the injection valve Rheodyne 9125 (USA). A 
PRP-X100 analytical and guard anion–exchange columns (Hamilton, Reno, 
NV, USA) were used. 
The analytical anion – exchange column MonoQ HR 5/5 (50 x 5 mm id.) 
(Pharmacia Biotech. Uppsala, Sweden) FPLC was used for fractionating of 
cytosol and  methanol:water extract. 
A gradient HPLC pump Jasco Pu 2089 plus (Tokyo, Japan) and  LKB 
model 2151 UV detector provided with a 10 µL flow cell was used for  absor-
bance monitoring during separation and measurements in the tandem FPLC 
– UV – ICP – MS.
Superdex (300 mm x 10 mm) and Phenomenex (300 mm x7.8 mm) (Phar-
macia Biotech. Uppsala, Sweden) analytical gel filtration columns were used 
to perform protein fractionating  in the cytosol, and the above mentioned Sep-
hadex G – 75 and G – 100 to perform protein fractionating after methanol : 
water extract. 
Solvent evaporation of methanol – water extracts and chromatographic 
fractions were performed in an Univapo100H – Unijet II system (Uniequip, 
USA). 
Materials, reagents and standards 
As(III) and As(V) standards were prepared from sodium arsenite and so-
dium arsenate (Sigma Aldrich, St Quintin, Fallavier, France), dimethylarsinic 
acid (DMA) and  methylarsonic acid (MMA) were obtained from Merck, and 
arsenobetaine (AsB) and arsenocholine (AsC) from Tri Chemical Laboratory 
Inc. (Japan). 
High-purity nitric and hydrochloric acids were obtained by distillation of 
the analytical-grade reagent (Merck) in an I.R. distiller (Berghof, BSB-939IR, 
Germany).
Proteins used for Size exclusion Chromatography (SEC)  calibration: Blue 
dextran 2000 (>2000 kDa); alcohol dehidrogenase (150 kDa); bovine albumin 
(66 kDa); carbonic anhidrase (29 kDa), cytochrome C (12.4 kDa); aprotine 
(6.5 kDa), B – 12 vitamin (1576 Da), Se-cystine (334 Da), Se-methionine (198 
Da) and Se-urea (123 Da) (Sigma Aldrich, St Quintin, Fallavier, France) and 
other chemicals were analytical reagent grade or the highest quality obtainable. 
Total arsenic determination and extraction for As species.
Details regarding the mineralization of tissues for total As determination 
and extraction of inorganic and methylated species in water:methanol extracts 
are given in previous papers10. 
Cytosol preparation
The  tissue was cut into little pieces, minced and homogenised in 2-3 mL 
of Tris solution [10 mM Tris, pH 7.4; 0.1 mM phenylmethylsulfoxyl fluoride 
(PMSF) and 25mM NaCl]. The mixture was centrifuged at 30 000 g. The su-
pernatant was further heated at 55ºC for 15 min to precipitate thermally labile 
proteins and then centrifuged at 30 000 g for 90 min to obtain the supernatant 
cytosol. This procedure is based on a modified protocol of G.M. Bogdan et 
al.14.
Procedures for As- protein fractionation in the cytosol by SEC and 
anion exchange protein chromatography
The fractionating  for cytosol and reconstituted methanolic extracts was 
carried out following a procedure similar to that reported by Ferrarello et al.15. 
The general procedure performed is summarised in FIGURE 1. 200 µL of the 
cytosol were applied to the Superdex peptide analytical column (100 – 7000 
Da). After the void volumes, 30 fractions of 1 mL each were collected using 
10 mM Tris–HCl [pH=7.4]– 0.1mM PMSF and 25 mM NaCl as mobile phase 
at 0.5 mL min-1 15. 
 The void volume, (about 30 mL), was evaporated up to 1 mL. The so-
lution was filtrated through a 0.22 µm cellulose filter, then it was again size 
fractionated using the analytical Phenomenex (1000 – 80 000 Da) column un-
der analogous conditions to those of  the Superdex column. The new pooled 
void volume was evaporated up to 1 mL. This volume was fractionated in the 
MonoQ HR 5/5 anion protein exchange column under analogous chromato-
graphic conditions. The chromatographically separated fractions of the differ-
ent columns (5 mL each), were evaporated up to 3 mL and analysed for  total 
protein content by the  Bradford´s method16 and for total As by Atomic Fluo-
rescence Spectrometer (AFS). The fractions having high protein and high As 
content were further analysed by FPLC-UV-ICP-MS for As – protein binding 
(200 µL injection volume) and by AELC-ICP-MS for As speciation of As(III), 
As(V), MMA, DMA, AsB and AsC (100µL injection volume). The proteins 
were measured at 280 nm using an UV detector for the first coupling. 32S, 65Cu 
and 31P were simultaneously monitored to 75As by ICP-MS. 
A fractionating procedure similar to that performed for the cytosol was 
used for the 1:1  methanol: water buffer reconstituted extracts using the Sep-
hadex G-75 (3000 – 80 000 Da)  and G–100 (4000 – 150 000 Da)  preparative 
columns, and finally the MonoQ HR 5/5. For the Sephadex columns, 5 mL of 
sample were introduced on the column head and fractions of 3 mL were col-
lected. The dead volume of the G-100 column (about 30 mL) was evaporated 
to 1 mL and introduced into the Mono Q HR 5/5. TABLA 1 shows the chro-
matographic conditions used for the FPLC-UV-ICP-MS and AELC-ICP-MS.
FIGURE 1:. Procedure: Size exclusion, anion protein exchange chroma-
tography and anion exchange chromatography of As species in the cytosol and 
methanolic extract.
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TABLE 1:. Chromatographic conditions  for protein separation by FPLC-UV-ICP-MS and As speciation by AELC-ICP-MS
FPLC-UV-ICP-MS AELC-ICP-MS
Anion Column:                                          MonoQ HR 5/5 Anion Column:                             Hamilton  PRP-X100
Injection volumes :                                    200 µL   Injection volumes :                      100 µL
Flow rate  :                                                 O.8  mL min-1   Flow rate  :                                  1.0  mL min-1
Mobile Phase (gradient) : A: 10 mM TRIS-HCl (pH= 7.4);           B: 
250 mM ammonium acetate + 10 mM TRIS-HCl (pH= 7.4)
Mobile Phase (isocratic) : 10 mM  Phosphate ammonium ( pH = 6)
Time (min)              B%       Time (min)                 B%
0                             0               10                           17
1.5                          2                11                          18
2                             3                12                          99
5.5                          4                19                       100 
6.0                        10                23                           0
RESULTS AND DISCUSSION
TABLA 2 shows the total As concentration of the cardiovascular tissues and some important characteristics of the evaluated impacted persons. Samples S–1 
and S-2 were used for the studies performed in the cytosol.  Samples S–3, S–4, S–5 and S–6 for the studies performed in the water–methanol batch extracts. Similar 
results were achieved from additional  analysed samples.
TABLA 2:. Individual information characteristics of the impacted people evaluated and total As concentration (µg g-1), in some of their cardiovascular tissues.
Total As content in the tissue (µg/g-1) Specific patient characteristics
Sample Auricle Saphene Age of the cardiac infarct
Working 
(living) As stigmas Others
S-1 3.9 ±0.2 2.5 ±0.2 37 Mine (Calama) yes Diabetes, dislipidemie
S-2 4.5 ±0.3 3.2 ±0.2 44 Mine yes Diabetes
S-3 5.4 ±0.4 2.6 ±0.3 45 Mine (Calama) Yes --
S-4 4.8 ±0.3 4.7 ±0.3 50 Mine (Antofagasta) yes --
S-5 4.8 ±0.4 5.2 ±0.4 53 Mine(Chuquicamata) yes Diabetes, anaemia
S-6 6.1 ±0.5 5.1 ±0.4 65 Person from I Region no --
Cytosol extracts.
FIGURE 2 (a – f), shows the total As (µg) and protein (µg) profiles of 
auricle and saphene tissues in the different fractions obtained for S–1 after 
Superdex, Phenomenex and MonoQ HR 5/5 fractionating. Analogous results 
were obtained for the auricle and saphene of S–2 sample (data not shown).
A–J dotted vertical lines, show the fraction at which the maximum peak 
of the proteins set used for calibration appeared. As was distributed within 
the three columns in a wide range of fractions  (about 9 – 22  in the Superdex, 
19 – 26 in the Phenomenex and 20 – 34 in the MonoQ HR columns). The 
similarity for the As and protein profile for both cytosol  tissues (especially for 
saphene) for most of the fractions obtained by the three columns could indicate 
an As – protein  association.
 The percentages of As in the collected fractions from the Superdex col-
umn was 8%. The molecular weight of the peptides that would be associated 
with As  from the  Superdex column, considering the biomolecular mass cali-
bration (lg MW= 3.92 - 0.44 K, r = 0.997), was within the ranges of 330-4600 
Da and 630-3600 Da for the auricle and saphenous tissues, respectively (FIG-
URE. 2(a) and 2(b).
From the Phenomenex fractionation the percentage of As in fraction col-
lected (FIGURES. 2(c) and 2(d).Was 25%. Considering the biomolecular mass 
calibration lg MW= 5.37 - 0.86 K, r = 0.980) we can infer the fraction of maxi-
mum As and protein content belong to species with a molecular weight within 
the 300 – 12 400 Da range. The presence of lower molecular weight16 species 
than were expected could be due to either the fragmentation of high molecular 
weight proteins inside the column or to other non – controlled processes.
The percentage of As in the fractions collected from the anion exchange 
MonoQ HR 5/5 column was 50% (FIGURE. 2(e) and 2(f). 
Calibration in the Superdex column: A = Aprotine (6500Da), B = B-12 
Vitamin (1576 Da), C = Se Cystine (334 Da), D = Se Methionine (198 Da), E 
= Se urea (123 Da).
Calibration in the Phenomenex column: F = Bovine serum (69 000 Da), 
G = Carbonic anhidrase (29 000 Da), H = Citochrome C (12 400 Da), I = Se 
cystine (334 Da) J = Se methionine (198 Da). 
In order to evaluate possible As association to the proteins, some repre-
sentative Superdex, Phenomenex and MonoQ HR 5/5 fractions of both auricle 
and saphene cytosol tissues were applied to FPLC–UV– ICP–MS. Besides, 
S, P, and Cu were monitored together with As. Cu was evaluated because 
the persons were exposed to copper mining activity impact, it is an important 
component of some metallothioneins and also of some high molecular mass 
proteins (HMMP) and enzymes17. S is present in amino acids such as cysteine 
residues involved in binding, transport, and storage of metals in the cells18. P 
was considered because is also an important component of some proteins and 
other biomolecules, such as ATP.
In FIGURE 3 (a and b) the most representative FPLC–UV–ICP–MS chro-
matograms from auricle and saphene  cytosol fractions with high As content 
after the Superdex fractionation  show that As, Cu, and S elute together, and at 
the same retention time as the maximum of the UV chromatogram (maximum 
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content of proteins). Thus, it can be deduced that As and Cu are in most cases 
bound to the same type of protein species.
The monitoring of the arsenic was not interfered with by the formation of 
ArCl+ , since the chloride concentration in the mobile phase raised the chro-
matographic baseline only slightly, and chloride concentration in the cytosolic 
extract does not exceed the minimum interferent level.
FIGURE 4. FPLC-UV-ICP-MS chromatogram of auricle S1; fraction 25 
after  Phenomenex fractionating.
FIGURE 5 (a - b) show two of the most representative chromatograms af-
ter MonoQ HR 5/5fractionation (obtained from fractions 22 and 24 for the auri-
cle and saphene tissue, respectively in the Phenomenex column) containing one 
or two As peaks. The first one in FIGURE 5a is always associated with Cu and 
S and also with P. As expected, most of the As is associated with polar proteins 
(as they elute at a high retention time from the anion exchange MonoQ column) 
of a molecular mass higher than 300 kDa (void volume of Phenomenex). FIG-
URE 2b, it is important to highlight that these fractions represent about 50% 
of the As content and, therefore, that the higher molecular mass of the cytosol 
protein (after Phenomenex fractionation) supports the higher As content.
Methanol : water extracts.
1:1 methanol:water mixtures are widely used for As speciation in bio-
logical tissues. This extractant mixture was used previously in preparative 
gel chromatography for arsenosugar detection in algae. In order to evaluate 
whether this mixture extracts the As bound to the cytosol proteins in its as-
sociated protein form, a similar study than performed above with the cytosol 
was carried out. Preparative gel chromatography using Sephadex G–75 (3–80 
kDa) and Shephadex G–100 (4–150 kDa) as reported and the anion protein 
exchange MonoQ HR 5/5, were used as it is shown in FIGURE 1. A very low 
content of As (<1% of total As) and protein were found in the different frac-
tions of both SEC / GFC fractionating series. However, a similar association 
As – protein to that found in the cytosol after MonoQ HR 5/5 fractionating was 
observed for the auricle and saphene. FIGURE 6 shows this association for 
the auricle of sample S-1. The As recovery found within the 25 – 33 fraction 
(corresponding to the higher MW cutting was 80% of the total arsenic. When 
FPLC–UV–ICP–MS was applied to the most representative As fractions of 
MonoQ HR 5/5, chromatograms (not shown) similar to those obtained for the 
cytosol were obtained. Therefore, we can assume that most of the As content in 
the methanol: water extract is bound to species that can probably be agglomer-
ated and solubilized in this extract. Cu,  As, S and P elute together in the same 
protein profile as in some of the preceding chromatograms. No differences in 
behaviour were detected between auricle and saphene.
FIGURE 2.: As (µg) and protein (µg) content in the auricle and saphene 
cytosol of S-1 after fractionating. (a): auricle in Superdex column ; (b): saphene 
in Superdex column; (c) auricle in Phenomenex column; d) saphene  in Phe-
nomenex column; (e) auricle in MonoQ HR 5/5 column; (f) saphene in MonoQ 
HR 5/5 column. 
FIGURE 3:. FPLC-UV-ICP-MS chromatograms of selected fractions 
from the Superdex column. (a) auricle S-1 fraction 18. ; (b) saphene S-1 frac-
tion 18.
It has been previously reported that As (III) is able to interact with metallo-
thioneins  (6–10 kDa), with   glutathione, forming an (AsSG)3 complex  (1040 
Da), and also with cysteine to produce an (As Cys)3 complex (501 Da), which 
gives a 3- coordinate cysteine environment for As18. These species have mo-
lecular masses within the range of the Superdex fractions. However, it is also 
important to note that P is not present in these species and therefore, the ATP 
or similar mass protein peptides should not be present.
FIGURE 4, the profile obtained by the FPLC–UV–ICP–MS coupling of 
one of the most representative fractions of the Phenomenex column for the 
auricle (S1) shows to peaks with very different retention times for As, which 
coelutes with S and P. This fact clearly indicates their association with differ-
ent types of proteins, both containing P. Cu also appears in the less retained 
protein. Arsenic may be bound to transferrin (80 kDa) and haemoglobin (64.5 
kDa) at its binding sites and through vicinal –SH- groups respectively18, and 
both have a molecular weight within the Phenomenex fractionating range. Sim-
ilar results were obtained in other fractions and for the saphene tissue. 
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FIGURE 5. FPLC-UV-ICP-MS chromatograms of selected  fractions 
from the MonoQ HR 5/5 column. (a) auricle S-2, fraction 22;  (b) saphene S-2, 
fraction 24. 
FIGURE 6.:As (µg) and protein (µg) content in 1:1 methanol:water ex-
tract after fractionating of auricle S-1 in the MonoQ HR 5/5 column.
As speciation in cytosol and methanol extracts.
As speciation within phenomenex 21–26 fractions of the cytosol from sa-
phene S-1 sample in which an As–protein overlapping occurs was performed 
to ascertain which As species are attached to the proteins. 
AELC–ICP–MS system with the Hamilton PRP–X100 column under 
conditions given in TABLE 2, shows the presence of only As(III) and As(V) 
in all the fractions FIGURE 7 Similar chromatograms were obtained in the 
methanol:water fractions of both tissues. The As(III) / As(V) ratio is constant 
in most of the fraction analysed. A recovery of 90 – 95% [As(III) + As(V) ] was 
found when total As was analysed in each fraction.
FIGURE 7: As(III) and As(V) chromatograms from consecutive fractions 
(20-26) of the phenomenex column from saphene S-1 cytosol.
CONCLUSIONS
This work can be considered as a first step in investigation on As bioac-
cumulation and the biochemical response of cardiovascular tissues proceeding 
from individuals chronically impacted by inorganic As. 
After methanol – water extraction, accounting for more than 80% of the 
total As content in the tissue, exclusively non-methylated species were found in 
the auricle. A very small amount of DMA was present in  saphene tissue. The 
absence of methylated species of As demonstrates the neglible capability of the 
vascular tissues for As methylation.
To summarise, in all the fractions analysed by FPLC-UV-ICP-MS from 
the different columns and tissues, the As and S are similarly associated, which 
could indicate that As is totally bound to biocompounds of different molecular 
mass through vicinal sulphur groups. The similarity of As and Cu behaviour in 
most cases indicates similar type of binding to the biomolecules. At the current 
stage no final conclusion could be drawn as to the specific protein with which 
As is associated. Although it is possible for the molecular weight of the native 
form of this As-binding protein to higher than 300 kDa, molecular fragmenta-
tion may occur experimental procedures.
For a deeper insight in As – protein association as part of the metabolism 
pathways additional studies are evidently necessary. Ongoing work is focussed 
on this aspect. 
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